Latest News for: wtx
Edit
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy ...
Nasdaq Globe Newswire 08 Oct 2025
Fast Track Designation underscores the promise of Werewolf’s INDUKINE™ platform ... .
Edit
Enid News & Eagle
08 Oct 2025
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an
Fast Track Designation underscores the promise of Werewolf’s INDUKINE™ platform ... .
Edit
The Eagle-Tribune
07 Oct 2025
WaveBreak Presents Human Brain Tissue Data Demonstrating Binding and Efficacy of Small Molecule WTX-607 Against ...
— Treatment of Parkinson's and Lewy body patient brain tissue with WTX-607 demonstrated highly specific binding to aggregates within neurons in patients' brain tissue and potent inhibition of alpha-synuclein aggregation — ... .
Edit
WaveBreak Presents Human Brain Tissue Data Demonstrating Binding and Efficacy of Small Molecule WTX-607 Against Alpha-Synuclein Aggregates for Parkinson's Disease and Lewy Body Dementia
PR Newswire 07 Oct 2025
— Treatment of Parkinson's and Lewy body patient brain tissue with WTX-607 demonstrated highly specific binding to aggregates within neurons in patients' brain tissue and potent inhibition of alpha-synuclein aggregation —.
- 1